Rongsheng Biotech

Company Deals

Rongsheng Bio Set for IPO on STAR Board to Boost Vaccine R&D

Fineline Cube Oct 25, 2022

Shanghai Rongsheng Biotech Co., Ltd is preparing to conduct an initial public offering (IPO) of...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod